Comparison of continuous infusion versus repeated bolus of Pralidoxime for the treatment of Organophosphosphate Pesticide poisoning
Keywords:
continuous infusion, Pralidoxime, Organophosphosphate, Pesticide poisoningAbstract
Background The present study compared the continuous infusion versus repeated bolus dose of pralidoxime for the management of organophosphate pesticide poisoning in terms of death(%), recovery (%), sequelae(%), mean atropine dose in 24hrs, mean ventilator days, total ICU stay, total hospital days, pneumonia, intermediate syndrome and its complications. Material and Methods This was a randomized control study. Carried out on 64 patients of either sex 15-65 years who presented in emergency medicine ward at Rajindra Hospital, Patiala. The patients who gave consent for the trial were given 2 gm of loading dose of pralidoxime over 30 mins and then randomized into two groups by simple random method:- Group I (n=32)– After loading dose, patients were given continuous infusion of pralidoxime 1gram/ hour for 48 hours. Group II (n=32) – After loading dose, patients were given repeated bolus dose of pralidoxime 1 gram/ hour every 4hourly for 48 hours.Thereafter, pralidoxime was continued at a rate of 1 gram/ hour every 4hourly till the patient was on ventilatory support. Result The mean atropine dose in group I was 32.7812± 7.17853 and in group II was 41.2812 ± 10.02974. The difference between them was statistically highly significant (p value <0.001). The mean ventilation days in group I was 5.2222 ± 2.97856 and in group II was 7.7037± 4.89753. The difference between them was statistically significant. (p value is 0.029). The mean hospital days in group I was 8.2188± 3.73937and in group II was 11.0938 ± 6.41248. The difference between them was statistically significant. (p value is 0.032). Conclusion With this study we concluded that, the infusion dose of pralidoxime was better than repeated bolus dose of pralidoxime in terms of mean atropine dose required mean ventilator days and total hospital stay.
Downloads
References
Johnson S, Peter JV, Thomas K, Jeyaseelan L, Cher ian AM. Evaluation of two treatment regimens of pralidoxime (1 gm single bolus dose vs 12 gm infusion) in the management of organophosphorus poisoning. J Assoc Physicians India. 1996; 44: 529–31.
Ch er ian AM, Peter JV, Joh n son S, et al. Effectiveness of oximes (PAM- Pralidoxime) in the treatment of organophosphorus poisoning (OPP) a randomised, double blind placebo controlled clinical trial. J Assoc Physicians India .1997; 45: 22–4.
Peter JV, Cherian AM. Organic insecticides. Anaesth Intensive Care.2000; 28: 11–21.
Eddleston M, Eyer P, Worek F, et al. Differences between organophosphorus insecticides in human self-poisoning: a prospective cohort study. Lancet . 2005; 366: 1452–9.
Sundwall A. Minimum concentrations of Nm e t h ylp y r id in iu m -2 -a ld o xim e m e t h a n e sulphonate (P2S) which reverse neuromuscular block. BiochemPharmacol. 1961; 8: 413–7
Eyer P. The role of oximes in the management of organophosphorus pesticide poisoning. Toxicol. Rev. 2003; 22:165-90.
Johnson K, Jacobsen D, Meredith TJ, Eyer P, Heath AJ, Ligtenstein DA, et al. Evaluation of antidotes for poisoning by organophosphorus pesticides. Emergency Medicine Australasia. 2000;12: 22-37
Johnson MK, Vale JA, Marrs TC, Meredith TJ. Pralidoxime for organophosphorus poisoning. Lancet .1992; 340: 64
Amos WC Jr, Hall A. Malathion poisoning treated with Protopam. Ann Intern Med. 1965; 62:1013- 16.
Eddleston M, Szinicz L, Eyer P, Buckley N. Oximes in acute organophosphorus pesticide poisoning: a systematic review of clinical trials. Q J Med. 2002;95:275–283.
Pawar KS, Bhoite RR, Pillay CP, Chavan SC, Ma ls h ik a r e DS, Ga r a d SG. Co n t in u o u s pralidoxime infusion versus repeated bolus injection to treat organophosphorus pesticide poisoning: a random ised controlled tr ial. Lancet.2006;368(9553): 2136-41.
Eddleston M, Eyer P, Worek F, Juszczak E, Alder N, Moh am ed F et al. Pr alid oxim e in acu te organophosphor us insecticide poisoning--a r a n d om is e d con t r olle d t r ia l. PLoS Me d . 2009;6(6):e1000104.
Mahesh M, Gowdar M, Venkatesh CR. A Study on Two Dose Regimens of Pralidoxime in the Management of Organophosphate Poisoning. Asia Pac J Med Toxicol. 2013; 2:121-5.
Lin CC, Hung DZ, Chen HY, Hsu KH. The effectiveness of patient-tailored treatment for acute organophosphate poisoning. Biomed J.2016;39:391-99
Cherian MA, Roshini C, Visalakshi J, Jeyaseelan L, Cherian AM. Biochemical and clinical profile after o r g a n o p h o s p h o r u s p o i s o n i n g - - a placebo-controlled tr ial using pralidoxime. Journal of the Association of Physicians of India 2005;53:427-31.
Banerjee I, Tripathi SK, Roy AS. A Study on Comparative Evaluation of Add-on Pralidoxime Therapy over Atropine in the Management of Organophosphorus Poisoning in a Tertiary Care Hospital. www.jkscience.org. 2011;13(2):65-69.
Bairy KL, Vidyasagar S, Sharma A, Sammad V. Co n t r o ve r s i e s i n t h e m a n a g e m e n t o f organophosphate pesticide poisoning. Indian Journal of Pharmacology.2007; 39: 71-74.
